iPSC-derived neuronal models of PANK2-associated neurodegeneration reveal mitochondrial dysfunction contributing to early disease

Mutations in PANK2 lead to neurodegeneration with brain iron accumulation. PANK2 has a role in the biosynthesis of coenzyme A (CoA) from dietary vitamin B5, but the neuropathological mechanism and reasons for iron accumulation remain unknown. In this study, atypical patient-derived fibroblasts were reprogrammed into induced pluripotent stem cells (iPSCs) and subsequently differentiated into cortical neuronal cells for studying disease mechanisms in human neurons. We observed no changes in PANK2 expression between control and patient cells, but a reduction in protein levels was apparent in patient cells. CoA homeostasis and cellular iron handling were normal, mitochondrial function was affected; displaying activated NADH-related and inhibited FADH-related respiration, resulting in increased mitochondrial membrane potential. This led to increased reactive oxygen species generation and lipid peroxidation in patient-derived neurons. These data suggest that mitochondrial deficiency is an early feature of the disease process and can be explained by altered NADH/FADH substrate supply to oxidative phosphorylation. Intriguingly, iron chelation appeared to exacerbate the mitochondrial phenotype in both control and patient neuronal cells. This raises caution for the use iron chelation therapy in general when iron accumulation is absent.

[1]  Baptiste N. Jaeger,et al.  An environment-dependent transcriptional network specifies human microglia identity , 2017, Science.

[2]  G. Borsani,et al.  Down-regulation of coasy, the gene associated with NBIA-VI, reduces Bmp signaling, perturbs dorso-ventral patterning and alters neuronal development in zebrafish , 2016, Scientific Reports.

[3]  V. Tiranti,et al.  Coenzyme A corrects pathological defects in human neurons of PANK2‐associated neurodegeneration , 2016, EMBO molecular medicine.

[4]  G. Borsani,et al.  Knock-down of pantothenate kinase 2 severely affects the development of the nervous and vascular system in zebrafish, providing new insights into PKAN disease , 2016, Neurobiology of Disease.

[5]  H. Houlden,et al.  Review: Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories , 2015, Neuropathology and applied neurobiology.

[6]  H. Petković,et al.  Extracellular 4'-phosphopantetheine is a source for intracellular coenzyme A synthesis. , 2015, Nature chemical biology.

[7]  V. Tiranti,et al.  Mitochondrial iron and energetic dysfunction distinguish fibroblasts and induced neurons from pantothenate kinase-associated neurodegeneration patients , 2015, Neurobiology of Disease.

[8]  Colin J. Mahoney,et al.  Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT , 2015, Human molecular genetics.

[9]  P. Hogarth.  Neurodegeneration with Brain Iron Accumulation: Diagnosis and Management , 2015, Journal of movement disorders.

[10]  A. Abramov,et al.  Measurement of mitochondrial NADH and FAD autofluorescence in live cells. , 2015, Methods in molecular biology.

[11]  A. Bush,et al.  β-Amyloid Precursor Protein Does Not Possess Ferroxidase Activity but Does Stabilize the Cell Surface Ferrous Iron Exporter Ferroportin , 2014, PloS one.

[12]  I. Gout,et al.  Changes in Acetyl CoA Levels during the Early Embryonic Development of Xenopus laevis , 2014, PloS one.

[13]  A. Gregory,et al.  Neurodegeneration with Brain Iron Accumulation Disorders Overview , 2014 .

[14]  S. Levi,et al.  Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms , 2014, Front. Pharmacol..

[15]  V. Tiranti,et al.  Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model , 2013, Brain : a journal of neurology.

[16]  T. Rouault,et al.  Iron metabolism in the CNS: implications for neurodegenerative diseases , 2013, Nature Reviews Neuroscience.

[17]  N. Andrews,et al.  Iron and copper in mitochondrial diseases. , 2013, Cell metabolism.

[18]  J. Hardy,et al.  Pantothenate kinase-associated neurodegeneration is not a synucleinopathy , 2012, Neuropathology and applied neurobiology.

[19]  S. Jackowski,et al.  Compartmentalization of Mammalian Pantothenate Kinases , 2012, PloS one.

[20]  B. Garavaglia,et al.  Skin fibroblasts from pantothenate kinase-associated neurodegeneration patients show altered cellular oxidative status and have defective iron-handling properties. , 2012, Human molecular genetics.

[21]  V. Tiranti,et al.  Pantothenate kinase-associated neurodegeneration: altered mitochondria membrane potential and defective respiration in Pank2 knock-out mouse model , 2012, Human molecular genetics.

[22]  Martin N. Rossor,et al.  Creation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease Research , 2012, PloS one.

[23]  J. Rehg,et al.  Germline Deletion of Pantothenate Kinases 1 and 2 Reveals the Key Roles for CoA in Postnatal Metabolism , 2012, PloS one.

[24]  Peter Kirwan,et al.  Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses , 2012, Nature Neuroscience.

[25]  J. Hardy,et al.  Syndromes of neurodegeneration with brain iron accumulation (NBIA): An update on clinical presentations, histological and genetic underpinnings, and treatment considerations , 2012, Movement disorders : official journal of the Movement Disorder Society.

[26]  A. Coulthard,et al.  Neuroferritinopathy: a new inborn error of iron metabolism , 2012, neurogenetics.

[27]  J. Eaton,et al.  The role of lysosomes in iron metabolism and recycling. , 2011, The international journal of biochemistry & cell biology.

[28]  Yasuko Matsumura,et al.  A more efficient method to generate integration-free human iPS cells , 2011, Nature Methods.

[29]  M. Grafe,et al.  Novel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurodegeneration. , 2011, Brain : a journal of neurology.

[30]  Mark Ellisman,et al.  Mitochondrial Rejuvenation After Induced Pluripotency , 2010, PloS one.

[31]  C. Masters,et al.  Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease , 2010, Cell.

[32]  Paolo Arosio,et al.  Pantothenate kinase-2 (Pank2) silencing causes cell growth reduction, cell-specific ferroportin upregulation and iron deregulation , 2010, Neurobiology of Disease.

[33]  C. Rock,et al.  Pantothenate Kinase 1 Is Required to Support the Metabolic Transition from the Fed to the Fasted State , 2010, PloS one.

[34]  O. Kayser,et al.  Pantethine rescues a Drosophila model for pantothenate kinase–associated neurodegeneration , 2010, Proceedings of the National Academy of Sciences.

[35]  Bing Zhou,et al.  Pantothenate kinase-associated neurodegeneration: insights from a Drosophila model. , 2009, Human molecular genetics.

[36]  C. Hoggart,et al.  Genome-wide association analysis of metabolic traits in a birth cohort from a founder population , 2008, Nature Genetics.

[37]  C. Rock,et al.  Localization and regulation of mouse pantothenate kinase 2 , 2007, FEBS letters.

[38]  T. Rouault.  The role of iron regulatory proteins in mammalian iron homeostasis and disease , 2006, Nature chemical biology.

[39]  H. Rowley,et al.  Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations. , 2006, AJNR. American journal of neuroradiology.

[40]  C. Rock,et al.  Biochemical Properties of Human Pantothenate Kinase 2 Isoforms and Mutations Linked to Pantothenate Kinase-associated Neurodegeneration* , 2006, Journal of Biological Chemistry.

[41]  J. Trojanowski,et al.  Altered Neuronal Mitochondrial Coenzyme A Synthesis in Neurodegeneration with Brain Iron Accumulation Caused by Abnormal Processing, Stability, and Catalytic Activity of Mutant Pantothenate Kinase 2 , 2005, The Journal of Neuroscience.

[42]  J. Connor,et al.  Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.

[43]  Shawn K. Westaway,et al.  A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome , 2001, Nature Genetics.

[44]  S. Kish,et al.  Hallervorden‐Spatz disease: Cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus , 1985, Annals of neurology.

[45]  J. R. Neely,et al.  Coenzyme A and carnitine distribution in normal and ischemic hearts. , 1978, The Journal of biological chemistry.

[46]  J. B. Allred,et al.  Determination of coenzyme A and acetyl CoA in tissue extracts. , 1969, Analytical biochemistry.